Author Archives: admin


Advanced Therapy Medicinal Products Market to Show Outstanding Growth by 2028 – StartupNG

Market Scenario of the Advanced Therapy Medicinal Products Market:

The industry study on Advanced Therapy Medicinal Products outlines national and global business prospects and competitive scenarios for Advanced Therapy Medicinal Products. Estimation of market size and projections were given based on a unique research design tailored to the complexities of the Advanced Therapy Medicinal Products.

Sample Copy of This Report @ https://www.quincemarketinsights.com/request-sample-68058?utm_source=SNG/KK

The prominent players covered in this report: Spark Therapeutics, Inc.; Bluebird Bio, Inc.; Novartis AG; UniQure N.V.; Celgene Corporation; Gilead Lifesciences, Inc.; Kolon TissueGene, Inc.; JCR Pharmaceuticals Co., Ltd.; MEDIPOST; Vericel Corporation; PHARMICELL Co., Ltd

Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, And South America.

The Advanced Therapy Medicinal Products market has been segmented By Therapy Type (Cell, CAR-T, Gene Therapy, Stem Cell, Non-stem Cell). Also, key factors impacting the growth of the Advanced Therapy Medicinal Products market have been identified with potential gravity.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Get ToC for the overview of the premium report @ https://www.quincemarketinsights.com/request-toc-68058?utm_source=SNG/KK

The Advanced Therapy Medicinal Products market report comprises domestic and global markets. This study on Advanced Therapy Medicinal Products market compiles internationally influential players and their business strategies to understand industry strategies. Some points that are the highlights are:

Reasons for buying this report:

Make an Enquiry for purchasing this Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-68058?utm_source=SNG/KK

About Us:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact Us:

Quince Market Insights

Ajay D. (Knowledge Partner)

Office No- A109

Pune, Maharashtra 411028

Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986

Email: [emailprotected]

Web: https://www.quincemarketinsights.com

Go here to see the original:
Advanced Therapy Medicinal Products Market to Show Outstanding Growth by 2028 - StartupNG

When old age catches up with you in your 30s – The Standard

Wayne Rooney was a football star during his time at Manchester United, accomplishing so much on the field. One of his greatest struggles was hair loss. At only 25, the football icon had started fighting with old age. Signs of old age start showing as early as when one is 30. By 40, you could develop sun spots, have shallow wrinkles or experience hair loss. While baldness in most men kicks in the 50s, like Wayne Rooney, you could experience it prematurely due to rare genetic conditions, says Arshni Malde, an aesthetic doctor at Tia Clinic in Nairobi.Some people are happy to embrace a new look and the challenges that come with old age but to others, sagging facial lines, deep wrinkles and a receding hairline can be a big blow to their confidence.I recommend a non-surgical facelift for people who want to look younger without incurring heavy financial costs, says Dr Arshni.As the skin matures, its structure weakens and it loses elasticity and firmness. This 60-minute anti-ageing procedure involves using products called threads that induce collagen in the skin, hence tightening it.The treatment works instantly in 70 per cent of patients I treat with the remaining small percentage experiencing full results by the end of two weeks. It will take one and a half to two years before the ageing process starts again at which we only do maintenance, Arshni says.The treatment costs an average Sh500,000.A solution to baldness

Original post:
When old age catches up with you in your 30s - The Standard

The 9th ISS R&D Conference Is Opening This Week, but This Year’s Setup Is Different – Science Times

The ninth annual International Space Station Research and Development Conference (ISSRDC) is set to open on Thursday, August 27, at 10 a.m. EDT, coinciding with the microgravity laboratory's 20th anniversary of continuous human presence in space.

NASA Administrator Jim Bridenstine will be opening this year's conference, with the theme "From Vision to Discovery," emphasizing how the past can help guide the future. The ISSRDC is going virtual this year, with the events spread over three nonconsecutive daysbut all falling on Thursdaysstarting this August 27, followed by a session on September 17, and the last being on October 22.

RELATED: Jeanette Epps Set to Be the First Black Woman to Join ISS Crew

According to NASA, the event is the only conference that explores in detail the full breadth of research and development currently underway on the orbiting laboratory, including future research to span the life of the ISS.

On the first Thursday of the ISSRDC, the session will focus on the space administration's commercialization initiative and updates from its leadership. The opening plenary session is also set to include a discussion regarding the evolution of the ISS US National Laboratory. Among the speakers set to appear on the August 27 session are Kathy Lueders, NASA's Human Exploration and Operations Mission Directorate Associate Administrator, and Dr. Thomas Zurbuchen, NASA Science Mission Directorate Associate Administrator.

The September 17 session will tackle business trends that affect the space station. Professor Alessandro Grattoni from the Houston Methodist Research Institute Department of Nanomedicine and Professor Aleksandar Ostrogorsky from the Illinois Institute of Technology's Mechanical and Materials Engineering Department will discuss how the ISS moves closer towards commercial applications.

For the third plenary day of the ISSRDC, NASA's press release announces that it will "touch on a myriad of science and educational activities." The session will focus on 20 years of student investigations enabled by the international space station. Keynote speakers for the third day include Mayo Clinic Director of Transfusion Medicine and Stem Cell Therapy Abba Zubair, New York Stem Cell Foundation Senior Research Investigator Valentina Fossati, Quest Institute's Danny Kim, and Genes in Space Lead Katy Martin.

The full schedule, including the list of speakers and moderators, can be found on the ISS Conference website.

The ISS is a modular space station and a habitable artificial satellite hovering in the Earth's orbit first launched on November 20, 1998. It started as a collaborative effort between the space agencies of five nations: United States (NASA), Russia (Roscosmos), Europe (ESA), Japan (JAXA), and Canada (CSA).

(Photo: Nasa/Getty Images) he International Space Station (ISS) is Backdropped Against The Blue And White Horizon Scene Of Earth And The Blackness Of Space Following Separation From Discovery June 3, 1999.

Since it was launched into space, the ISS has become a space environment and a microgravity research platform for different countriesconducting studies in various fields including astrobiology, meteorology, physics, chemistry, and more. This coming November, according to NASA, its international and commercial partners will be celebrating the 20th year of having humans continuously live and work at the ISS.

RELATED: SpaceX, NASA On the Lookout Before Endeavor Splashdown

Since 2000, it has already accommodated 240 people from 19 countries, across almost 400 flights. Among the achievements by the space environment and microgravity lab include hosting more than 3,000 research inquiries designed by researchers from more than 100 countries.

Check out more news and information on Space and otherNASA Missionson Science Times.

Original post:
The 9th ISS R&D Conference Is Opening This Week, but This Year's Setup Is Different - Science Times

Platelet rich plasma and thicker hair | Empty Nest – NorthFulton.com

Everyone would like to have thicker hair. Well, almost everyone -- but our focus today is not on those rare unicorns whose complaint is that their hair is just too thick, too luxurious and too lustrous. This article is for the rest of us who would like to have more or thicker hair or at least stop losing what we have.

A number of treatment options have been the staple considerations for normal male and female pattern hair loss for years. For men, finasteride, minoxidil and hair transplantation have long been the most effective interventions. Womens treatment options used to be even more limited, with minoxidil alone being the main option for female pattern hair loss. However, a growing body of research supports that hormone replacement and/or platelet rich plasma injections could be the miracle grow for failing follicles!

First, a note about hormone replacement therapy: A physician named Dr. Glaser published an article in the British Journal of Dermatology in 2012 which made an observation that has unfortunately gained little attention likely because it runs counter to how people usually think about hair loss and testosterone. Dr. Glaser surveyed 285 women who had been on subcutaneous testosterone therapy for more than a year for the treatment of androgen deficiency and 63% of the women who had reported hair thinning prior to treatment reported hair thickening after treatment began. This finding has received little attention, but a 63% response rate deserves further investigation.

Several patients in my own clinic who complained of thinning hair, went on androgen replacement prescribed by their endocrinologist or ob-gyn for other reasons. These patients hair became markedly thicker and more voluminous on testosterone. Although Premier Dermatology does not offer hormone replacement therapy (HRT), androgen levels are one of the laboratory tests that we order as part of our screening panel for causes of hair loss. If we have a female hair loss patient with low androgen levels (either low or low normal), we offer referral to a physician who performs HRT for discussion of risks and benefits of a trial of androgen replacement therapy for hair loss. Results that we have seen have paralleled the 63% response rate that Dr. Glaser published.

Second and just as exciting, Platelet Rich Plasma, also known as PRP, is an option that is fast becoming an important treatment strategy for treating hair loss in both men and women, be it for common hair thinning or for certain alopecia syndromes. PRP is a blood product derived from a patients own blood. The process involves the following: A fraction of blood (up to 22ml in our practice) is drawn from the individual patient into a syringe (depends on the extent of hair loss). This is a relatively small amount compared to blood donation. The blood then is spun in a centrifuge to separate its components (White & Red Blood Cells, Platelet Rich Plasma and Platelet Poor Plasma). The Platelet Rich Plasma (PRP) is collected into a syringe. The PRP is then injected into a treatment area (the scalp for hair loss).

The basis behind PRP is that growth factors and other proteins within platelets promote healing and induce tissue regeneration and rejuvenation. Platelets contain growth factors and biologically active molecules that are normally released when platelets are outside of blood vessels such as when a person gets a cut and starts to bleed into surrounding tissue. Injecting PRP into the subdermal fat induces platelet degranulation (release of platelet contents) which causes tissue exposure to platelet growth factors. In plain terms, PRP delivers growth factors to stimulate hair follicles.

To achieve best results, PRP is performed in a series of treatments. Typically, two to three treatments are performed once per month initially. It is often recommended that treatments take place every 6 months after the initial series of treatments to continue hair regeneration and maintain or enhance results.

PRP has numerous other applications in dermatology the most common of which is as an adjunct to microneedling for skin rejuvenation or treatment of acne scars. However, PRPs greatest potential may be as a treatment to help grow or maintain hair.

At Premier Dermatology and Mohs Surgery of Atlanta, we are committed to offering scientifically-backed, effective and state of the art treatments. Kathryn Filipek, PA-C has extensive cosmetic, surgical and medical dermatology experience and is responsible for the hair loss branch of our practice. If you are interested in exploring PRP and hair loss options, call today to make an appointment with Ms. Filipek. It is our privilege to take care of you and your familys skin, vein, and hair care needs.https://premierdermatologyatlanta.com/

Link:
Platelet rich plasma and thicker hair | Empty Nest - NorthFulton.com

Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Research Study 2020 Insights with COVID-19 Impact Analysis by 2020Orange…

Report is a detailed study of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market, which covers all the essential information required by a new market entrant as well as the existing players to gain a deeper understanding of the market.The primary objective of this research report named Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market is to help making reliable strategic decisions regarding the opportunities in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market. It offers business accounts, industry investors, and industry segments with consequential insights enhancing decision making ability.[emailprotected] or call us on +1-312-376-8303.

Request Report from CMR Website:https://cognitivemarketresearch.com/pharma-%26-healthcare/stem-cell-and-platelet-rich-plasma-%28prp%29-alopecia-therapies-market-report

Global and Regional Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Segmentation by Type: Platelet Rich Plasma Injections, Stem Cell Therapy

Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Segmentation by Applications: Dermatology Clinics, Hospitals

Major Market Players with an in-depth analysis: Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Anderson Center for Hair, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, Virginia Surgical Center, Hair Transplant Institute of Miami, Colorado Surgical Center & Hair Institute

Request Free Sample Copy of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Research [emailprotected] https://cognitivemarketresearch.com/pharma-%26-healthcare/stem-cell-and-platelet-rich-plasma-%28prp%29-alopecia-therapies-market-report#download_report

The Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market report offers the current state of the market around the world. The report starts with the market outline and key components of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market which assumes a significant job for clients to settle on the business choice. It additionally offers the key focuses to upgrade the development in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market. Some fundamental ideas are likewise secured by reports, for example, item definition, its application, industry esteem chain structure and division which help the client to break down the market without any problem. Also, the report covers different factors, for example, arrangements, efficient and innovative which are affecting the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies business and market elements.

Any query? Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample): Click Here> Download Sample Report of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Report 2020 (Coronavirus Impact Analysis on Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market)

The research comprises primary information about the products. Similarly, it includes supply-demand statistics, and segments that constrain the growth of an industry. It also includes raw materials used and manufacturing process of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market. Additionally, report provides market drivers and challenges & opportunities for overall market in the particular provincial sections.

Competitive Analysis has been done to understand overall market which will be helpful to take decisions. Major players involved in the manufacture of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies product has been completely profiled along with their SWOT. Some of the key players include Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Anderson Center for Hair, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, Virginia Surgical Center, Hair Transplant Institute of Miami, Colorado Surgical Center & Hair Institute. It helps in understanding their strategy and activities. Business strategy described for every company helps to get idea about the current trends of company. The industry intelligence study of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market covers the estimation size of the market each in phrases of value (Mn/Bn USD) and volume (tons). Report involves detailed chapter on COVID 19 and its impact on this market. Additionally, it involves changing consumer behavior due to outbreak of COVID 19.

Further, report consists of Porters Five Forces and BCG matrix as well as product life cycle to help you in taking wise decisions. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Regional Analysis for Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies North America (United States, Canada) Europe (Germany, Spain, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, India, Australia, and South Korea) Latin America (Brazil, Mexico, etc.) The Middle East and Africa (GCC and South Africa)

DOWNLOAD FREE SAMPLE [emailprotected]: https://cognitivemarketresearch.com/pharma-%26-healthcare/stem-cell-and-platelet-rich-plasma-%28prp%29-alopecia-therapies-market-report#download_report

Chapters Define in TOC (Table of Content) of the Report: Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation Overview Chapter 2: COVID Impact Chapter 3: Market Competition by Manufacturers Chapter 4: Production by Regions Chapter 5: Consumption by Regions Chapter 6: Production, By Types, Revenue and Market share by Types Chapter 7: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 8: Complete profiling and analysis of Manufacturers Chapter 9: Manufacturing cost analysis, Raw materials analysis, Region-wise Manufacturing expenses Chapter 10: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 11: Marketing Strategy Analysis, Distributors/Traders Chapter 12: Market Effect Factors Analysis Chapter 13: Market Forecast Chapter 14: Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Research Findings and Conclusion, Appendix, methodology and data source To check the complete Table of Content click here: @ https://cognitivemarketresearch.com/pharma-%26-healthcare/stem-cell-and-platelet-rich-plasma-%28prp%29-alopecia-therapies-market-report#table_of_contents

The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market. The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2027.

About Us: Cognitive Market Research is one of the finest and most efficient Market Research and Consulting firm. The company strives to provide research studies which include syndicate research, customized research, round the clock assistance service, monthly subscription services, and consulting services to our clients.

Contact Us: +1-312-376-8303 Email: [emailprotected] Web: https://www.cognitivemarketresearch.com/

**********Download the Entire Report************************************************* https://cognitivemarketresearch.com/pharma-%26-healthcare/stem-cell-and-platelet-rich-plasma-%28prp%29-alopecia-therapies-market-report

Original post:
Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Research Study 2020 Insights with COVID-19 Impact Analysis by 2020Orange...

Joint Pain Injections Market Size 2020 | Covid 19 Impact Analysis | Global Industry Trends, Growth, Share, Size and Forecast – StartupNG

Market Scenario of the Joint Pain Injections Market:

The industry study on Joint Pain Injections outlines national and global business prospects and competitive scenarios for Joint Pain Injections. Estimation of market size and projections were given based on a unique research design tailored to the complexities of the Joint Pain Injections.

Sample Copy of This Report @ https://www.quincemarketinsights.com/request-sample-65228?utm_source=SNG/KK

The prominent players covered in this report: Anika Therapeutics, Inc., Bioventus, Ferring Pharmaceuticals Inc., Sanofi, Zimmer Biomet.

Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, And South America.

The Joint Pain Injections market has been segmented By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections)By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint). Also, key factors impacting the growth of the Joint Pain Injections market have been identified with potential gravity.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Get ToC for the overview of the premium report @ https://www.quincemarketinsights.com/request-toc-65228?utm_source=SNG/KK

The Joint Pain Injections market report comprises domestic and global markets. This study on Joint Pain Injections market compiles internationally influential players and their business strategies to understand industry strategies. Some points that are the highlights are:

Reasons for buying this report:

Make an Enquiry for purchasing this Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-65228?utm_source=SNG/KK

About Us:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact Us:

Quince Market Insights

Ajay D. (Knowledge Partner)

Office No- A109

Pune, Maharashtra 411028

Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986

Email: [emailprotected]

Web: https://www.quincemarketinsights.com

Read more here:
Joint Pain Injections Market Size 2020 | Covid 19 Impact Analysis | Global Industry Trends, Growth, Share, Size and Forecast - StartupNG

Porzingis hoping to play again this season if Mavs can get past Clippers – The Official Home of the Dallas Mavericks – Mavs.com

Kristaps Porzingis isnt quite sure if the lateral menisus tear in his right knee will eventually require surgery. But the Dallas Mavericks forward is holding out hope that it wont.

An MRI performed earlier this week revealed the tear, and Porzingis said he had been taking some Platelet-Rich Plasma (PRP) injections to help alleviate the pain.

Were hoping with the injections that it could help me, Porzingis said on Saturday. Hopefully the meniscus can kind of I dont know how it works exactly but repair itself with the injections.

But it depends on how Im going to feel in the next two weeks and then I think the medical staff is going to make a decision whether I need that (surgery) or not.

One thing is for sure: Porzingis wont play in Game 6 of the Mavs Western Conference quarterfinals series against the Los Angeles Clippers. The game tips off Sunday at 2:30 p.m. inside the NBA bubble with the Clippers leading the series, 3-2.

Porzingis also hasnt been medically cleared to play if the series between the Mavs and Clippers reaches a Game 7.

My hope is that if we have a chance to advance (to the conference semifinals), maybe somehow I can get the knee better and play, Porzingis said. I tried to go now and practice, and it just wasnt the medical staff just didnt accept me playing and doing more.

So for now, I dont know. Im going to be here, because if I was able to play through it, then maybe I can keep playing through it at some point. Just now Im doing intense treatment and doing all I can to improve the knee, and then well see where we go.

Porzingis said he originally injured his knee while battling for an offensive rebound in the first half of Game 1 of this series. But he continued to play in that game, and in the ensuing two contests before missing the past two games.

I think somebody kind of fell on (the knee), Porzingis said. I think it was (Marcus) Morris (Sr.), on accident, obviously, and I felt something in my knee. But I just kept playing through it, and then at halftime I told the medical staff my knee was bothering me a little bit.

They worked on it and I was good to go in the second half, and thats when I got ejected and then my knee locked up after Game 1. Somehow we were able to get it going (for Game 2) it felt good.

However, Porzingis said in Game 3 his knee got worse. And just before the tipoff of Game 4, the pain in his knee was so excruciating that Porzingis was a last-minute scratch.

Right before the game (4) I just couldnt get anything going and its super disappointing, super frustrating, he said. But Ive learned how to accept that feeling and look forward to whats next.

Porzingis has learned how to accept that feeling because of what happened to him on Feb. 6, 2018. Thats the day Porzingis tore his left anterior cruciate ligament after landing awkwardly following a dunk in a road game against the Milwaukee Bucks while he was playing for the New York Knicks.

Porzingis underwent surgery on Feb. 13, 2018, was traded to the Mavs on Jan, 31, 2019, and made his Mavs debut on opening day this season.

So as far as knee injuries go, Porzingis has been there, done that. And the Mavs hope his right knee responds favorably to treatment and hell be able to play if they can somehow win two more games against the Clippers.

The door is not closed on the entire season if we are able to advance, coach Rick Carlisle said. When I spoke to you (media) guys on Wednesday about this, he had practiced, he was sore. It was clear that hes doing everything that he can.

The guys been doing treatment, I dont know, 10 hours a day. . .and it just wasnt progressing the way that he had hoped. He was on the floor today and did some shooting and did a little bit of moving around, so he wants to keep the door open to possibly play if we can move on, but its a very tough situation, but hes trying his best.

Someone asked Porzingis if he was worried about his future in the NBA due to injuries to each of his two knees, or if he thought these were just isolated incidents. His response?

I cant really be too worried about that, Porzingis said. Both of (the injuries) were contact injuries, and these things happen. What I can do is focus on the work that I can put in to make sure that I decrease the possibility of that happening.

That means strengthening everything and just trying to do all of the preventive work I can, and thats in my hands. Again, its a contact sport and these things can happen, so I cant be too frustrated over these kinds of things.

At the time of his injury, Porzingis was playing some of the best basketball of his career. Overall, the 7-3, 240-pounder averaged 20.4 points, 9.5 rebounds and 2.0 blocks per game this season.

Also, Porzingis had 34 points and 13 rebounds in Game 3 against the Clippers. Its the first time a member of the Mavs produced a 30-point, 10-rebound game in the postseason since Dirk Nowitzki collected 34 points and 11 rebounds in Game 3 of the 2011 NBA Finals against the Miami Heat.

Clearly, Porzingis is a major centerpiece to what the Mavs are trying to get accomplished.

Obviously I was (feeling) bad for a little bit for a little while once I found out what happened in the knee, Porzingis said. But I was able to accept that feeling and move past that pretty quickly and look into whats next and go on from there. Obviously if this is the end for my season, it has a bitter end, although I think my year as it went on I got into a better rhythm and I started playing better basketball with each game.

I feel like now once I go into the offseason and make sure I get the knee healthy, Im looking forward to just thinking picking up where I left off and keep playing that high level of basketball and look forward to the next things we can accomplish as a team.

Still, Porzingis shrugs at the mere thought that he may have played his last game this season.

Ive got to thank the medical staff, he said. They put in crazy hours with me and in the treatment room and in the weight room. But at this point it was just a little too much maybe, and they dont want me to push it any more, so were here and were going day-by-day.

Its hard to not be able to be out there with the guys and fight, especially in a series like this thats so much fun. Its really tough and frustrating, but it is what it is and now Im looking forward to getting healthy.

Twitter: @DwainPrice

More here:
Porzingis hoping to play again this season if Mavs can get past Clippers - The Official Home of the Dallas Mavericks - Mavs.com

5 Recent Tech Innovations Disrupting the Medical and Healthcare Industry – HealthTechZone

Technology is at our fingertips. Think of all the health monitors or wearable fitness trackers that people are using today. Virtual healthcare practices have changed our attitude towards the medical and healthcare industry. While there are loyalists as well as dissenters who rue the lack of personal connection with the doctor and quality care, tech innovations are breaking barriers meanwhile.

Technology in Healthcare

It could be as simple as information sharing between doctors and patients, or something as profound as robotic aid in a high-risk surgery. Better still, make it a remote surgery where the patient and doctor are separated by miles in between them! Clearly, recent tech advancements are disrupting the medical and healthcare industry with its dynamic applications.

It started with the online consultations and took off from there.

Telemedicine or virtual consultations are a thing of the past now. Even when they started, the dramatic impact it had on traditional healthcare roles has changed our collective attitude towards the industry. As these technologies develop further, more applications for professionals and patients stand to promote the overall wellness. Today, apps on the phone track our exercise and calorie intake, check obesity development, and monitor heart health.

Here are 5 recent tech innovations that have disrupted the industry for the long haul:

1. Virtual Reality or AR/MR/VR in Healthcare

Both medical professionals and patients stand to benefit from the multi-sensory, immersive experience that VR provides.

Think of realistic and low-risk simulated environment for training surgeons. On the other hand, in the arena of pain management or mental health, immersion in virtual worlds can produce better results. VRs therapeutic potential and rehabilitation chances in acute pain and anxiety disorder cases are far-reaching.

2. Nanomedicine

This is the stuff of sci-fi genres. Nanotechnology and nanodevices are arming the healthcare industry with control on the molecular level. Nanopharmaceuticals are aiming at smaller drugs and more precise delivery systems. For instance, delivering chemotherapy to targeted tumours rather than poisoning the whole body.

3. 3D Printing

Creating medical tools from buildable materials ranging from plastic to stem-cells, 3D printing has revolutionised the medical industry. Aided by the custom-friendly aspect of 3D printing, organ transplants and tissue repair, prosthetics and braces, even layered stem-cell organoids are possible today. Faster prototypes at a fraction of the traditional cost is a huge leg-up in the healthcare scene. The most dazzling innovation through this method is the poly-pill that holds several drugs for multiple illnesses with different release times!

4. Internet of Medical Things or IoT

Connected devices, cloud-computing, and the internet have allowed a larger the exchange of data, convenience, and automation. The IoT is significantly changing how healthcare professionals can manage patient records, control inventory, monitor and provide preventative care. In a way, this could be the most significant disruptive technology as a lot of other tech advancements have been possible only through this.

5. Precision Medicine

Diagnosis, treatment, and preventive care based on an individuals environment, lifestyle, and genetic makeup is a big shift from the all-purpose generic approach. Precision medicine is suggested based on diagnostic and molecular genetic testing processes such as genome sequencing and DNA mutation investigations. This will revolutionise preventive measures reducing treatment time and expenditure as well as healthcare requirement.

As healthcare and technological advancements grow together, the industry becomes more optimised providing quality care. It is evident in the cosmetic health industry where non-surgical procedures have advanced significantly. You can get Botox in Perth with breakthrough serums and great aftercare with minimal or no recovery time.

In fact, tech innovations have disrupted the healthcare industry so significantly, it is impossible to see it survive without them.

Follow this link:
5 Recent Tech Innovations Disrupting the Medical and Healthcare Industry - HealthTechZone

A New FMI Report Forecasts the Impact of COVID-19 Pandemic on Stem Cell Therapies Market Growth Post 2020 – The Scarlet

With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and medical device industries. FMI deploys digital intelligence solutions to offer compelling insights to report buyers that help them in overcoming market challenges, especially at the time of a crisis. Our dedicated team of professionals performs an extensive survey for gathering accurate information associated with the market.

FMI, in its upcoming business report, elaborates the historical and current scenario of the Stem Cell Therapies in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Crucial information and forecast statistics covered in the Stem Cell Therapies report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

COVID-19 Impact Analysis on Stem Cell Therapies

The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Stem Cell Therapies. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Stem Cell Therapies.

Following governments measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMIs report includes an interesting chapter on preliminary impact of the COVID-19 on the Stem Cell Therapies. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Why Choose Future Market Insights

Discounted prices for new customers! Offer expires soon!

Request Report [emailprotected] https://www.futuremarketinsights.com/reports/sample/rep-gb-1087

Stem Cell Therapies market: segmentation

To analyze the Marketing Stem Cell Therapies effectively and efficiently, the information has been segregated into key segments and sub-segments.

On the basis of treatment:

On the basis of application:

Stem Cell Therapies: Competition Analysis

The FMIs study presents a comprehensive analysis of global, regional, and country-level players active in the Stem Cell Therapies. Competitive information detailed in the Stem Cell Therapies report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Stem Cell Therapies report.

Key players covered in the report include:

Request Methodology of this Report @ https://www.futuremarketinsights.com/askus/rep-gb-1087

Important Questions Answered in the Stem Cell Therapies Report

Key Offerings of the Report

About Us Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us Mr. Abhishek Budholiya 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): + 44 (0) 20 7692 8790 Sales: [emailprotected] Press Office: [emailprotected] Blog: Market Research Blog Website: https:www.futuremarketinsights.com

Excerpt from:
A New FMI Report Forecasts the Impact of COVID-19 Pandemic on Stem Cell Therapies Market Growth Post 2020 - The Scarlet

Cell Harvesting Market 2018 Analysis Of Production, Future Demand, Sales And Consumption Research Report To 2023 – The Scarlet

The global market for cell harvesting should grow from $885 million in 2018 to reach $1.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.3% for the period of 2018-2023.

Report Scope:

The scope of the report encompasses the major types of cell harvesting that have been used and the cell harvesting technologies that are being developed by industry, government agencies and nonprofits. It analyzes current market status, examines drivers on future markets and presents forecasts of growth over the next five years.

The report provides a summary of the market, including a market snapshot and profiles of key players in the cell harvesting market. It provides an exhaustive segmentation analysis of the market with in-depth information about each segment. The overview section of the report provides a description of market trends and market dynamics, including drivers, restraints and opportunities. it provides information about market developments and future trends that can be useful for organizations, including wholesalers and exporters. It provides market positionings of key players using yardsticks of revenue, product portfolio, and recent activities. It further includes strategies adopted by emerging market players with strategic recommendations for new market entrants. Readers will also find historical and current market sizes and a discussion of the markets future potential. The report will help market players and new entrants make informed decisions about the production and exports of goods and services.

Get Access to sample pages @https://www.trendsmarketresearch.com/report/sample/11685

Report Includes:

41 data tables and 22 additional tables Description of segments and dynamics of the cell harvesting market Analyses of global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023 Characterization and quantification of market potential for cell harvesting by type of harvesting, procedure, end user, component/equipment and region A brief study and intact information about the market development, and future trends that can be useful for the organizations involved in Elaboration on the influence of government regulations, current technology, and the economic factors that will shape the future marketplace Key patents analysis and new product developments in cell harvesting market Detailed profiles of major companies of the industry, including Becton, Dickinson and Co., Corning, Inc., Fluidigm Corp., General Electric Co., Perkinelmer, Inc., and Thermo Fisher Scientific, Inc.

Summary

Stem cells are unspecialized cells that have the ability to divide indefinitely and produce specialized cells. The appropriate physiological and experimental conditions provided to the unspecialized cells give rise to certain specialized cells, including nerve cells, heart muscle cells and blood cells. Stem cells can divide and renew themselves over long periods of time. These cells are extensively found in multicellular organisms, wherein mammals, there are two types of stem cells embryonic stem cells and adult stemcells. Embryonic stem cells are derived from a human embryo four or five days old that is in the blastocyst phase of development. Adult stem cells grow after the development of the embryo and are found in tissues such as bone marrow, brain, blood vessels, blood, skin, skeletal muscles and liver. Stemcell culture is the process of harvesting the exosomes and molecules released by the stem cells for the development of therapeutics for chronic diseases such as cancer and diabetes. The process is widely used in biomedical applications such as therapy, diagnosis and biological drug production. The global cell harvesting market is likely to witness a growth rate of REDACTED during the forecast period of 2018-2023.The value of global cell harvesting market was REDACTED in 2017 and is projected to reach REDACTED by 2023. Market growth is attributed to factors such as increasing R&D spending in cell-based research,the introduction of 3D cell culture technology, increasing government funding, and the growing prevalence of chronic diseases such as cancer and diabetes.

The growing incidence and prevalence of cancer is seen as one of the major factors contributing to the growth of the global cell harvesting market. According to the World Health Organization (WHO), cancer is the second-leading cause of mortality globally and was responsible for an estimated 9.6 million deaths in 2018. Therefore, there is an increasing need for effective cancer treatment solutions globally. Cell harvesting is the preferred method used in cancer cell-related studies including cancer cell databases (cancer cell lines), and other analyses and drug discovery in a microenvironment. The rising prevalence of such chronic diseases has led governments to provide R&D funding to research institutes and biotechnology companies to develop advanced therapeutics. Various 3D cell culture technologies have been developed by researchers and biotechnology companies such as Lonza Group and Thermo Fischer Scientific for research applications such as cancer drug discovery. The application of cell culture in cancer research is leading to more predictive models for research, drug discovery and regenerative medicine applications.

Platelet-rich plasma (PRP) therapy, a new biotechnology solution that has a heightened interest among researchers in tissue engineering and cell-based therapies, has various applications in the treatment of tissue healing in tendinopathy, osteoarthritis and muscle injury. It has been conventionally employed in orthopedics, maxillofacial surgery, periodontal therapy and sports medicines. PRP therapy can be used in the treatment of fat grafting, acne scars, and hair regrowth.

Major factors driving market growth include increasing healthcare costs and the high rate of adoption for modern medicines in emerging economies such as China and India. It has been estimated that India will witness a CAGR of REDACTED in the cell harvesting market during the forecast period. The active participation of foreign pharmaceutical companies has tapped the Indian healthcare sector with a series of partnerships and mergers and acquisitions, which in turn is positively impacting the growth of the market in this region. Consistent development and clinical trials for stem cell therapies, plus contribution from the government and private sectors through investments and cohesive reimbursement policies in the development of cancer biomarkers, is further fueling market growth. InSweden, a research team at Lund University has developed a device to collect fluid and harvest stem mesenchymal stem cells (MSCs). The device is developed with 3D-printed bio-inert plastics which, when used by doctors, can result in the safe extraction of fluids (medical waste) from the patients body. The liquid is then passed through a gauze filter for purifying thoroughly and MSCs are separated from the fluid by centrifugation and are grown in culture.

Follow this link:
Cell Harvesting Market 2018 Analysis Of Production, Future Demand, Sales And Consumption Research Report To 2023 - The Scarlet